Лечение и препараты

FDA Approval of Essential Thrombocythemia Drug is “Important Milestone”

What Does Personalization of Radiopharmaceutical Therapy Require?

Zanidatamab Plus Chemotherapy Extends OS in First-Line HER2+ Advanced GEA

Oral Adherence and Access in Long-Term Targeted Therapy

Preparing Patients for Bispecific-Antibody Based First-Line Therapy

Supporting Patients When First-Line Therapy Intensifies

Managing Diarrhea and Nutrition on First-Line EGFR Therapy

Daraxonrasib becomes the first FDA approved RAS-targeted therapy in pancreatic cancer - Oncology Central

Daraxonrasib becomes the first FDA approved RAS-targeted therapy in pancreatic cancer Oncology Central

CAR T-Cell Therapy is a Blood Cancer Breakthrough. But What About Quality of Life? - news.cuanschutz.edu

CAR T-Cell Therapy is a Blood Cancer Breakthrough. But What About Quality of Life? news.cuanschutz.edu

Novel Agent Earns FDA Breakthrough Therapy Designation for HPV+ Oropharyngeal Cancer

Speaking With “One Voice” for World Radiotherapy Awareness Day

New therapy treatment for cancer being tested at Penn Medicine: "The data's been really promising" - CBS News

New therapy treatment for cancer being tested at Penn Medicine: "The data's been really promising" CBS News

How Penn Medicine is testing a new proton therapy treatment for cancer - CBS News

How Penn Medicine is testing a new proton therapy treatment for cancer CBS News

Без тяжелой терапии: ученые нашли способ атаковать рак мозга прямо через кость череп - Правда.Ру

Без тяжелой терапии: ученые нашли способ атаковать рак мозга прямо через кость череп Правда.Ру

What Do Clinicians Get Right About Radiopharmaceutical Therapy?